-- Crew Energy Brief: National Bank Adds It Expects CR to "Positively participate and benefit from an expanded long-term value proposition in association with the materiality of the pro-forma business-March 2024-www.financetom.com

-- Crew Energy Brief: National Bank Adds It Expects CR to "Positively participate and benefit from an expanded long-term value proposition in association with the materiality of the pro-forma business

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Aug 12, 2024 12:10 PM

02:40 PM EDT, 08/12/2024 (MT Newswires) --

Price: 6.90, Change: +3.00, Percent Change: +76.92

Previous page： Deals of the day-Mergers and acquisitions Next page： Safety Shot Rebrands as Sure Shot

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Deals of the day-Mergers and acquisitions

Oct 9, 2024

Oct 9 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1400 GMT on Wednesday: ** Abu Dhabi's sovereign wealth fund, one of the largest shareholders in Thames Water, has written off its nearly 9.9% stake in the troubled British utility, the Financial Times reported. ** China's Zijin Mining Group will buy the Akyem Gold Mine Project...

Safety Shot Rebrands as Sure Shot

Oct 9, 2024

08:59 AM EDT, 10/09/2024 (MT Newswires) -- Safety Shot ( SHOT ) said Wednesday it has rebranded as Sure Shot. The company said it teamed up with full-service agency Amalgam, which led the rebranding effort in partnership with Stout Design. Price: 1.2795, Change: +0.02, Percent Change: +1.55 ...

Capricor Therapeutics Submits Biologics License Application to FDA for Duchenne Muscular Dystrophy Drug Candidate

Oct 9, 2024

10:00 AM EDT, 10/09/2024 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said Wednesday that it has initiated a rolling submission with the US Food and Drug Administration for a biologics license application for deramiocel to treat patients with Duchenne muscular dystrophy cardiomyopathy. The biotech company said it expects to complete the rolling submission by the end of the year...

Hyundai to use $3 bln record India IPO proceeds for new cars, R&D

Oct 9, 2024

* Hyundai IPO biggest ever in India, Asia's biggest in 2024 * Company wants to expand in India; first listing outside S.Korea * Hyundai aims to make India a manufacturing hub for emerging mkts * Executive says 30% increase in production seen in 3-4 years (Adds details, comments in paragraph 7, 11, 16-17) By Dhwani Pandya MUMBAI, Oct 9 (Reuters)...